摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-phenyl-3-methyl-4-(tert-butylacetyl)-5-pyrazolone | 216253-66-6

中文名称
——
中文别名
——
英文名称
1-phenyl-3-methyl-4-(tert-butylacetyl)-5-pyrazolone
英文别名
1-phenyl-3-methyl-4-neopentylcarbonylpyrazol-5-one;1-phenyl-3-methyl-4-tert-butylacetyl-pyrazol-5-one;4-tert-butylacetyl-3-methyl-1-phenylpyrazol-5-one;4-(3,3-dimethylbutanoyl)-5-methyl-2-phenyl-4H-pyrazol-3-one
1-phenyl-3-methyl-4-(tert-butylacetyl)-5-pyrazolone化学式
CAS
216253-66-6
化学式
C16H20N2O2
mdl
——
分子量
272.347
InChiKey
RRHQLAXVILJEKM-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.9
  • 重原子数:
    20
  • 可旋转键数:
    4
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.44
  • 拓扑面积:
    49.7
  • 氢给体数:
    0
  • 氢受体数:
    3

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    1-phenyl-3-methyl-4-(tert-butylacetyl)-5-pyrazolone 在 calcium chloride 、 potassium hydroxide 作用下, 以 乙醇 为溶剂, 以84%的产率得到bis(4-t-butylacetyl-3-methyl-1-phenylpyrazol-5-onato)bis(ethanol)calcium(II)
    参考文献:
    名称:
    Inhibitory effect of β-diketones and their metal complexes on TNF-α induced expression of ICAM-1 on human endothelial cells
    摘要:
    Recent reports show that the natural beta-diketone curcumin displays important biological properties regarding the intercellular adhesion molecule-1 (ICAM-1), which plays a critical role in the immune responses and inflammation. In this study the ICAM-1 inhibitory activity of beta-diketone compounds, which are curcumin models lacking aromatic peripheral hydroxyl and methoxy groups, along with some metal derivatives is investigated. beta-Diketones are systematically more active than metal complexes and the best obtained inhibition is 75% for both groups. The best inhibitors are 4-benzoyl-3-methyl-1-phenyl-pyrazol- 5-one (HQ(Ph)) among the ligands, and sodium benzoylacetonato among metal derivatives. These results appear in line with the reported antitumor activity of related species. Since 4-acyl-5-pyrazolones posses four tautomeric forms, those corresponding to HQ(Ph) were investigated using density functional theory. Docking of all HQ(Ph) tautomers on ICAM-1 protein was performed suggesting one keto-enol form favored to act in biological environment. (C) 2009 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmc.2009.07.064
  • 作为产物:
    参考文献:
    名称:
    具有酰基吡唑啉酮和含磷配体的混合配体镧系元素络合物
    摘要:
    用量子化学方法对乙酰丙酮镧与各种含磷农药,有毒气体及其水解产物的反应进行了建模。在大多数情况下,有机磷化合物取代水的焓为负。在使用乙酸乙酯(二乙氧基磷酰基)乙酸乙酯作为模型化合物的溶液中研究复合物。合成了具有酰基吡唑啉酮和乙酸乙酯(二乙氧基磷酰基)的混合配体镧系元素络合物。确定for络合物的晶体结构。
    DOI:
    10.1134/s1070328413030020
点击查看最新优质反应信息

文献信息

  • Electroluminescent materials and devices
    申请人:Kathirgamanathan Poopathy
    公开号:US20070259208A1
    公开(公告)日:2007-11-08
    An electroluminescent composition is provided comprising: (a) a compound of the general chemical formula (I): wherein M is lithium, sodium, potassium, rubidium, caesium, beryllium, magnesium, calcium, strontium, barium, copper, silver, gold, zinc, boron, aluminum, gallium, indium, germanium, tin, antimony, lead, manganese, iron, ruthenium, osmium, cobalt, rhodium, iridium, nickel, palladium, platinum, cadmium or chromium; n is the valence of M; and R 1 , R 2 and R 3 can be the same or different, and are selected from hydrogen, a substituted or unsubstituted aliphatic group, a substituted or unsubstituted aromatic, heterocyclic or polycyclic ring structure, a fluorocarbon, a halogen or a nitrile group; and (b) a suitable dopant. The composition may be used in forming electroluminescent devices.
    提供了一种电致发光组合物,包括:(a)一种具有一般化学式(I)的化合物:其中M是锂、钠、钾、铷、铯、铍、镁、钙、锶、钡、铜、银、金、锌、硼、铝、镓、铟、锗、锡、锑、铅、锰、铁、钌、铑、铱、镍、钯、铂、镉或铬;n是M的价;R1、R2和R3可以相同也可以不同,并且选择自氢、取代或未取代的脂肪基、取代或未取代的芳香、杂环或多环环状结构、氟碳化合物、卤素或腈基;以及(b)适当的掺杂剂。该组合物可用于制造电致发光器件。
  • Marchetti, Fabio; Pettinari, Claudio; Cingolani, Augusto, Journal of the Chemical Society, Dalton Transactions, 1998, # 19, p. 3325 - 3333
    作者:Marchetti, Fabio、Pettinari, Claudio、Cingolani, Augusto、Leonesi, Dante、Drozdov, Andrei、Troyanov, Sergei I.
    DOI:——
    日期:——
  • The Effect of Different Neutral Ligands on Photoluminescence and Electroluminescence Properties of Ternary Terbium Complexes
    作者:Hao Xin、Mei Shi、Xi Cun Gao、Yan Yi Huang、Ze Liang Gong、Dao Bo Nie、Hong Cao、Zu Qiang Bian、Fu You Li、Chun Hui Huang
    DOI:10.1021/jp037816h
    日期:2004.7.1
    Three terbium complexes Tb(tba-PMP)(3)(TPPO) (A), Tb(tba-PMP)(3)(H2O) (B), and Tb(tba-PMP)(3)(Phen) (C) (where tba-PMP, TPPO, and Phen stand for beta-diketone 1-phenyl-3-methyl-4-(tert-butylacetyl)-5-pyrazolone, triphenyl phosphine oxide, and 1,10-phenanthroline, respectively) with different neutral ligands were synthesized and characterized, and the mechanism of how the neutral ligands affect photoluminescence (PL) and electroluminescence (EL) properties of terbium complexes was studied. Experiments revealed neutral ligand TPPO and Phen strongly affect the terbium complex PL intensity, TPPO enhanced the PL intensity of complex A, while Phen reduced the PL intensity of complex C compared to that of complex B. Investigation indicated this is caused by the different excited energy levels between tba-PMP, TPPO, and Phen, which were obtained from their phosphorescence spectra measured with their corresponding gadolinium complexes Gd(tba-PMP)(3)(H2O)(EtOH), Gd(TPPO)(2)(NO3)(3), and Gd(Phen)(2)(NO3)(3), Compared to complex B, the energy absorbed by TPPO can be efficiently transferred to tba-PMP and the central ion Tb3+ due to its excited singlet and triplet energy levels matching that of tba-PMP and the D-5(4) energy level of Tb3+, and consequently enhancing the PL intensity of A, while on the contrary, negative energy transfer occurred between Phen and tab-PMP or Tb3+ since the triplet energy level of Phen is lower than that of tba-PMP and the D-5(4) energy level of Tb3+ as well. Experimental results show terbium complex electroluminescence (EL) is greatly dependent on its PL intensity, the performance achieved based on complexes A, B, and C being 9540 cd/m(2) and 7.2 lm/W, 3230 cd/m(2) and 1. 17 lm/W, and 690 cd/m(2) and 0.13 lm/W, respectively, with the power efficiency ratio A:B:C 55:9:1, which was greatly enlarged compared to their PL intensity ratio A:B:C = 2.1:1.3:1.
  • Synthesis, Molecular Structure (X-ray and DFT), and Solution Behavior of Titanium 4-Acyl-5-pyrazolonates. Correlations with Related Antitumor β-Diketonato Derivatives
    作者:Francesco Caruso、Claudio Pettinari、Fabio Marchetti、Paolo Natanti、Christine Phillips、Joseph Tanski、Miriam Rossi
    DOI:10.1021/ic700935x
    日期:2007.9.1
    Previously reported structure-activity relationships have shown two features for effective antitumor activity of titanium beta-diketone complexes: (a) ligand asymmetry and (b) the presence of planar substitutents on the ligand. Mono- and dinuclear derivatives, studied with diffraction and DFT methods show that (a) is consistent with different Ti-O(beta-diketonato) bond lengths, which are longer than Ti-O(oxo) and Ti-O(alkoxy) ones. pi-pi features observed in dinuclear derivatives correlate with strong reactivity of related complexes with DNA and support DNA intercalation by such planar groups, in agreement with (b). Large variation for Ti-O bond lengths and Ti-O-C bond angles in the ethoxy moiety is associated with the titanium withdrawing effect and oxygen bonding s character; it is confirmed through exploration of the Cambridge crystallographic database. This ethoxy geometrical flexibility also suggests versatile accommodation in protein pockets and/or other biological targets. Electrospray ionization mass spectrometry (ESI-MS) spectra show formation of di- and trinuclear Ti-4-acyl-5-pyrazolonato cationic oligomers. Hydrolysis/oligomerization is also described by NMR results.
  • US7211334B2
    申请人:——
    公开号:US7211334B2
    公开(公告)日:2007-05-01
查看更多

同类化合物

(4S,4''S)-2,2''-环亚丙基双[4-叔丁基-4,5-二氢恶唑] 香豆素-6-羧酸 锌离子载体IV 钐(III) 离子载体 II 苯,(2,2-二氟乙烯基)- 聚二硫二噻唑烷 缩胆囊肽9 甲酰乙内脲 甲巯咪唑 甲基羟甲基油基噁唑啉 甲基5-羟基-3,5-二甲基-4,5-二氢-1H-吡唑-1-羧酸酯 甲基5-甲基-4,5-二氢-1H-吡唑-1-羧酸酯 甲基5-氰基-4,5-二氢-1,2-恶唑-3-羧酸酯 甲基5-乙炔基-4,5-二氢-1H-吡唑-3-羧酸酯 甲基4-甲基-5-氧代-4,5-二氢-1H-吡唑-3-羧酸酯 甲基4-甲基-4,5-二氢-1H-吡唑-3-羧酸酯 甲基4-乙炔基-4,5-二氢-1H-吡唑-3-羧酸酯 甲基4,5-二氮杂螺[2.4]庚-5-烯-6-羧酸酯 甲基4,5-二氢-5-乙基-1H-吡唑-1-羧酸酯 甲基(E)-3-[6-[1-羟基-1-(4-甲基苯基)-3-(1-吡咯烷基)丙基]-2-吡啶基]丙烯酰酸酯 甲基(5-氧代-4,5-二氢-1,2-恶唑-3-基)乙酸酯 环戊二烯并[d]咪唑-2,5(1H,3H)-二硫酮 溶剂黄93 溴化1-十六烷基-3-甲基咪唑 溴化1-十二烷基-2,3-二甲基咪唑 泰比培南酯中间体 泰比培南酯中间体 氨基甲硫酸,[2-[[(2-羰基-1-咪唑烷基)硫代甲基]氨基]乙基]-,O-甲基酯 异噻唑,4,5-二氯-2,5-二氢-2-辛基- 希诺米啉 四氟硼酸二氢1,3-二(叔-丁基)-4,5--1H-咪唑正离子 四唑硝基紫 噻唑丁炎酮 噻唑,4,5-二氢-4-(1-甲基乙基)-,(S)- 噁唑,4,5-二氢-4,4-二甲基-2-(5-甲基-2-呋喃基)- 噁唑,2-庚基-4,5-二氢- 咪唑烷基脲 吡嗪,2,3-二氢-5,6-二甲基-2-丙基- 叔-丁基3-羟基-1,4,6,7-四氢吡唑并[4,3-c]吡啶-5-羧酸酯 双吡唑啉酮 双[(S)-4-异丙基-4,5-二氢噁唑-2-基]甲烷 双((R)-4-(叔丁基)-4,5-二氢恶唑-2-基)甲烷 利美尼啶D4 利美尼啶 假硫代乙内酰脲 依达拉奉杂质DO 依达拉奉杂质 依达拉奉三聚体 依达拉奉 仲班酸